Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Witherspoon

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Transplantation|February 1, 1982
Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humansK Atkinson, R Storb, H D Ochs, et al.
Transplantation|May 1, 1983
Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host diseaseK T Izutsu, K M Sullivan, M M Schubert, et al.
Blood|May 23, 2001
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantationJ Storek, M A Dawson, B Storer, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
Bone Marrow Transplantation|December 3, 2003
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantationJ Storek, M A Dawson, L C-L Lim, et al.
Blood|May 15, 1997
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trialH J Deeg, D Lin, W Leisenring, et al.
The New England Journal of Medicine|March 27, 1997
Solid cancers after bone marrow transplantationR E Curtis, P A Rowlings, H J Deeg, et al.
Blood|April 1, 1983
Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?R Storb, R L Prentice, M Banaji, et al.
The New England Journal of Medicine|February 10, 1983
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environmentR Storb, R L Prentice, C D Buckner, et al.
Blood|August 1, 1996
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantationP J Martin, B J Nelson, F R Appelbaum, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Transplantation|February 1, 1982
Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humansK Atkinson, R Storb, H D Ochs, et al.
Transplantation|May 1, 1983
Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host diseaseK T Izutsu, K M Sullivan, M M Schubert, et al.
Blood|May 23, 2001
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantationJ Storek, M A Dawson, B Storer, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
Bone Marrow Transplantation|December 3, 2003
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantationJ Storek, M A Dawson, L C-L Lim, et al.
Blood|May 15, 1997
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trialH J Deeg, D Lin, W Leisenring, et al.
The New England Journal of Medicine|March 27, 1997
Solid cancers after bone marrow transplantationR E Curtis, P A Rowlings, H J Deeg, et al.
Blood|April 1, 1983
Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?R Storb, R L Prentice, M Banaji, et al.
The New England Journal of Medicine|February 10, 1983
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environmentR Storb, R L Prentice, C D Buckner, et al.
Blood|August 1, 1996
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantationP J Martin, B J Nelson, F R Appelbaum, et al.
Pageof 11